Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FASA Sec. 1555 repeal

This article was originally published in The Gray Sheet

Executive Summary

FASA Sec. 1555 repeal: Treasury & Postal Appropriations conference report would repeal provisions in the Federal Acquisition Streamlining Act allowing state and local governments to purchase goods and services, including medical products, at discounted prices outlined in the General Services Administration's federal supply schedule. HR 2378 was passed by the House Sept. 30 and the Senate the following day...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008896

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel